SIC 8071 – Medical Laboratories
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | n/a |
| Book Value / Share | n/a |
| Price / Book | n/a |
| NCAV ($M) | 0.00 |
| NCAV / Share | n/a |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | n/a |
| Assets | n/a |
| Liabilities | n/a |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | n/a |
| Operating Income | n/a |
| Net Income | n/a |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | n/a |
| Cash from Investing | n/a |
| Cash from Financing | n/a |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Nikko Asset Management Americas, Inc. | 5.85 | -2.85 | |
| 13G/A | Vanguard Group Inc | 5.12 | -35.10 | |
| 13G/A | Sumitomo Mitsui Trust Holdings, Inc. | 5.85 | -2.85 | |
| 13G/A | ARK Investment Management LLC | 11.36 | 20.23 | |
| 13G/A | BlackRock Inc. | 6.70 | -11.53 | |
| 13G | Flynn James E | 4.90 | 55,737.49 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| HALB – Halberd Corporation | LUDG – Ludwig Enterprises, Inc. |
| MEDD – Medical Imaging Corp. | PCHM – PharmChem, Inc. |
| RTNXF – Renalytix Plc |
Financial data and stock pages provided by
Fintel.io